DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

DRG and its group companies would like to inform you that we have updated our website privacy policy.

Acknowledge
› Putting Together the Perfect Market...

Putting Together the Perfect Market Access Strategy with Insights

We leverage our unparalleled market access data and analysis to deliver personalized, actionable insights, from pre-launch through product maturity and down to the hyper local level to answer the most important questions your Market Access Team faces and help to supercharge your activity and results.

Integrated Delivery Networks

QUESTION

How should the growing power of IDNs and the move towards risk based contracting with providers affect your strategy and approach to contracting with payers?

ANSWER
Provider organizations that have a high level of control or responsibility for the cost of care are likely to exert more influence over the pull-through of contracts with payers for formulary placement. It is important to understand when payer contracts may be more challenging to pull through because of powerful IDNs within a payer’s network.

RESOURCES

Health Plans and PBMs

QUESTION

What are payers doing to assert their position in the market and gain control by vertically integrating with PBMs and physician organizations?

ANSWER
MCOs are joining with PBMs and physician organizations. Examples include CVS/Aetna, UnitedHealth/OptumRX/DaVita, and Cigna/Express Scripts.  Achieving greater scale and cutting out middlemen should allow companies like CVS Health to cut medication costs in the short term, as they’ll enjoy greater leverage over the drug and device companies across the table and can realize efficiencies when they control the point of care, the means of distribution and the purse strings.

RESOURCES

Value Based Contracting

QUESTION

How does the move towards value based care impact your approach to engaging payers and providers that control benefit design and delivery of care?

ANSWER
It is important to engage with risk-bearing providers – and the payers with whom they contract – regarding the value of drug therapies and the evidence for the effectiveness of those drugs. As the healthcare industry moves away from the fee-for-service model, it is critical to understand how payers and providers approach cost and quality.

RESOURCES

Leverage DRG’s Market Access Insights Platform to

  • Understand the data and accelerate your success
  • Stage your deals right the first time with pinpoint accuracy in each state and major market.
  • Reduce internal silos with solutions designed for your entire team

 

Get the very latest analysis from our expert analysts and see why we are your execution experts

Learn more about IDNs

Get the resources you need to plan for and approach IDNs as they continue to gain leverage in US markets.

Dig Deeper

Stream our recent webinar!

Mega-IDNs Rattle Payer Landscape: As Dominant Provider Systems Gain Control, MCOs Fight Back.

Stream Now

Gauge the shift towards value based contracting

As US healthcare continues to evolve, it’s more important than ever to stay on top of value based contracting and the way it has shifted the landscape of healthcare delivery.

Learn more

Your Provider of Market Access Intelligence

Data Integration and Management from People Who Know the Industry AND the Data

 

  • A single-source-of-truth for market access data

We combine more data in more ways than anyone else, offering the granularity to anticipate market change and the flexibility to respond quickly.

  • Meaningful insights to keep teams up-to-date with the most local markets and significant customers

Dedicated market access experts add context to the data, detailing the impact of customer activity and media consumption habits as well as new regulations and regulatory activity on the horizon.

  • Custom services for complex challenges—specific to your brand

Advanced analytics maximize evidence from disparate data assets

Learning curriculums to optimize team performance

Collaborative consulting support across the product lifecycle